標(biāo)題: Titlebook: Current Strategies in Cancer Gene Therapy; Wolfgang Walther Book 2016 Springer International Publishing Switzerland 2016 Cancer.Clinical T [打印本頁(yè)] 作者: STRI 時(shí)間: 2025-3-21 17:40
書(shū)目名稱(chēng)Current Strategies in Cancer Gene Therapy影響因子(影響力)
書(shū)目名稱(chēng)Current Strategies in Cancer Gene Therapy影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Current Strategies in Cancer Gene Therapy網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Current Strategies in Cancer Gene Therapy網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Current Strategies in Cancer Gene Therapy被引頻次
書(shū)目名稱(chēng)Current Strategies in Cancer Gene Therapy被引頻次學(xué)科排名
書(shū)目名稱(chēng)Current Strategies in Cancer Gene Therapy年度引用
書(shū)目名稱(chēng)Current Strategies in Cancer Gene Therapy年度引用學(xué)科排名
書(shū)目名稱(chēng)Current Strategies in Cancer Gene Therapy讀者反饋
書(shū)目名稱(chēng)Current Strategies in Cancer Gene Therapy讀者反饋學(xué)科排名
作者: engrossed 時(shí)間: 2025-3-21 22:36 作者: 一條卷發(fā) 時(shí)間: 2025-3-22 03:11 作者: 紅腫 時(shí)間: 2025-3-22 05:47
mRNA Cancer Vaccines,ccinate patients, mRNAs can also be used in cellular therapies to transfect patient-derived cells in vitro and infuse the manipulated cells back into the patient. One such application is the transfection of patient-derived dendritic cells (DCs) with mRNAs encoding TAAs, which leads to the presentati作者: wall-stress 時(shí)間: 2025-3-22 12:07 作者: 網(wǎng)絡(luò)添麻煩 時(shí)間: 2025-3-22 14:00 作者: 網(wǎng)絡(luò)添麻煩 時(shí)間: 2025-3-22 18:49
0080-0015 or design, vector delivery, and therapeutic efficacy. It offers readers a stimulating, broad overview of advances in the field, linking experimental strategies to their clinical applications..978-3-319-82697-4978-3-319-42934-2Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: 休閑 時(shí)間: 2025-3-23 00:27
https://doi.org/10.1007/978-3-031-05046-6uss recent advances in our understanding of the molecular basis of the p53-mediated cell death signaling pathway and therapeutic methods for enhancing tumor cell death and induction of bystander effects within tumor tissues in p53 replacement therapy. Exploration of the molecular mechanism underlyin作者: MULTI 時(shí)間: 2025-3-23 03:34 作者: 下級(jí) 時(shí)間: 2025-3-23 07:23 作者: 挑剔小責(zé) 時(shí)間: 2025-3-23 10:01 作者: Intractable 時(shí)間: 2025-3-23 15:52
https://doi.org/10.1007/978-3-031-06497-5ontext, lytic bacterial toxins, such as streptolysin O (SLO) or the claudin-targeted . enterotoxin (CPE) represent attractive new types of suicide oncoleaking genes. They permit as pore-forming proteins rapid and also selective toxicity toward a broad range of cancers. In this chapter, we describe t作者: expansive 時(shí)間: 2025-3-23 21:34 作者: 未完成 時(shí)間: 2025-3-24 00:42
0080-0015 gies and their clinical applications.Includes supplementary This book describes important developments and emerging trends in experimental and clinical cancer gene therapy. It reflects the tremendous advances made over recent years with respect to immunogenes, suicide genes and gene correction thera作者: plasma 時(shí)間: 2025-3-24 05:16 作者: 巨碩 時(shí)間: 2025-3-24 07:36 作者: 陳舊 時(shí)間: 2025-3-24 12:34 作者: landmark 時(shí)間: 2025-3-24 16:53
Roland Bernecker,Nicole Franceschinizyme-, RNA interference-, and CRISPR/Cas9-based techniques. Various delivery strategies were used to reverse MDR in different tumor models in vitro and in vivo. Results and conclusions of these gene therapeutic studies will be discussed.作者: 慢慢啃 時(shí)間: 2025-3-24 22:33 作者: Additive 時(shí)間: 2025-3-25 00:24 作者: Peristalsis 時(shí)間: 2025-3-25 06:49
Wolfgang WaltherProvides a broad overview of current developments in gene therapy.Includes novel approaches in cancer gene therapy.Links experimental strategies and their clinical applications.Includes supplementary 作者: engagement 時(shí)間: 2025-3-25 11:02
Recent Results in Cancer Researchhttp://image.papertrans.cn/d/image/241325.jpg作者: 我沒(méi)有命令 時(shí)間: 2025-3-25 15:40
https://doi.org/10.1007/978-3-319-42934-2Cancer; Clinical Trials; Gene Targeting; Gene Therapy; Gene Transfer; Viral and Nonviral Vectors作者: 油膏 時(shí)間: 2025-3-25 17:57
978-3-319-82697-4Springer International Publishing Switzerland 2016作者: HEPA-filter 時(shí)間: 2025-3-25 21:44
Current Strategies in Cancer Gene Therapy978-3-319-42934-2Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: 強(qiáng)所 時(shí)間: 2025-3-26 00:23 作者: opinionated 時(shí)間: 2025-3-26 05:13
Po-Wen Chi,Ming-Hung Wang,Yun-Hsin Chuangtein expression patterns in several human diseases, including cancer. This information has driven the development of novel therapeutic strategies, such as the utilization of small molecules to target specific cellular pathways and the use of retroviral vectors to retarget immune cells to recognize a作者: Hypopnea 時(shí)間: 2025-3-26 11:23 作者: 大炮 時(shí)間: 2025-3-26 12:59
An Active User-Side Detector for Evil Twinssorders. A subset of noncoding RNAs, microRNAs (miRNAs) and small interference RNAs (siRNAs), compose an important class of widely used effectors for gene therapy, especially in cancer treatment. Functioning through the RNA interference (RNAi) mechanism, miRNA and siRNA show potent ability in silenc作者: Enzyme 時(shí)間: 2025-3-26 16:52 作者: Banquet 時(shí)間: 2025-3-27 01:02
Roland Bernecker,Nicole Franceschinier expression of trans-membrane xenobiotic transport molecules belonging to the superfamily of ATP-binding cassette (ABC)-transporters. This protein family includes the classical MDR-associated transporter ABCB1 (MDR1/P-gp). Inhibition of ABC-transporters by low molecular weight compounds in cancer 作者: heartburn 時(shí)間: 2025-3-27 02:39
https://doi.org/10.1007/978-3-031-06497-5lize non-toxic prodrugs into toxic compounds, leading to the effective suicidal killing of the transfected tumor cells. In this regard, the suicide gene therapy has demonstrated its potential for efficient tumor eradication. Numerous suicide genes of viral or bacterial origin were isolated, characte作者: essential-fats 時(shí)間: 2025-3-27 05:26
https://doi.org/10.1007/978-3-031-06497-5d because of the existing pharmacological side effects of the conventional chemotherapy, radiation, or surgery. Newer modalities such as cancer vaccines and biological therapies are proving very helpful in the treatment of cancer along with the conventional therapies. The success of these novel canc作者: Abduct 時(shí)間: 2025-3-27 12:19
p53 Replacement Therapy for Cancer, tumors develop through genetic alterations in TSGs. The most potent therapeutic TSG for tumor suppression is the multifunctional transcription factor p53 gene that regulates diverse cellular phenomena such as cell cycle arrest, senescence, apoptosis, and autophagy. Since the p53 gene is frequently 作者: 加入 時(shí)間: 2025-3-27 16:38 作者: 帶傷害 時(shí)間: 2025-3-27 21:35 作者: cylinder 時(shí)間: 2025-3-28 01:32 作者: Antigen 時(shí)間: 2025-3-28 03:16 作者: 階層 時(shí)間: 2025-3-28 06:47 作者: LAIR 時(shí)間: 2025-3-28 11:09 作者: Adjourn 時(shí)間: 2025-3-28 16:40 作者: Assemble 時(shí)間: 2025-3-28 21:17 作者: refine 時(shí)間: 2025-3-28 23:42